Sara Honari, MD
Surgery · Brooklyn, NYNPI 1194042168
Payments from drug & device makers
Across 190 payments — averaging $36.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$2K
- Smith+Nephew$1K
- Silk Road Medical, Inc.$874
- Cook Medical LLC$549
- Inari Medical, Inc.$538
- Lemaitre Vascular, Inc.$462
- plus $2K from 24 others
What the payments were for
- Travel & lodging$1,03515%
- Food & beverage$5,82385%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 13 | $1,555 |
| Smith+Nephew | 62 | $1,189 |
| Silk Road Medical, Inc. | 19 | $874 |
| Cook Medical LLC | 10 | $549 |
| Inari Medical, Inc. | 9 | $538 |
| Lemaitre Vascular, Inc. | 17 | $462 |
| Medtronic(2 entities) | 6 | $306 |
| Artivion, Inc. | 4 | $152 |
| Boston Scientific | 5 | $114 |
| Getinge USA Sales, LLC | 5 | $114 |
| Shockwave Medical, Inc | 1 | $114 |
| Pfizer | 7 | $112 |
| Bolton Medical Inc | 1 | $103 |
| Livanova USA, Inc. | 4 | $90 |
| Johnson & Johnson | 5 | $84 |
| Tactile Systems Technology Inc | 5 | $69 |
| Medline Industries LP | 1 | $64 |
| Bard Peripheral Vascular, Inc. | 2 | $44 |
| Cardiovascular Systems Inc. | 3 | $42 |
| Organogenesis Inc. | 1 | $42 |
| Cagent Vascular Inc | 1 | $36 |
| Reflow Medical Inc | 1 | $35 |
| Acell, Inc. | 1 | $30 |
| Inspiremd Ltd | 1 | $29 |
| Surmodics, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $18 |
| Abiomed | 1 | $17 |
| Vertex | 1 | $17 |
| Avinger Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE TAG Conformable Thoracic Stent Graft$576
- ENROUTE Transcarotid Neuroprotection System$517
- ENROUTE Transcarotid Stent$381
- GORE TAG Thoracic Endoprosthesis$288
- Stravix$252
- GORE TAG Thoracic Branch Endoprosthesis$170
- Endurant$170
- FLOWTRIEVER CATHETER, S$151
- CT THROMBECTOMY SYSTEM KIT$151
- Lunderquist$148
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$135
- GRAFIX PL$133
- GORE TAG Conformable Thoracic Endoprosthesis$124
- ARTEGRAFT VASCULAR GRAFT$123
- Cook Medical Zenith$119
- Grafix$119
- Oasis$119
- Zenith$114
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$114
- TREO ABDOMINAL STENT-GRAFT SYSTEM$103
How this compares
$6,858 in reported general payments places this provider in the 75th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 29 | $21,412 |
| EliquisApixaban | 19 | $17,102 |
| ClopidogrelClopidogrel Bisulfate | 178 | $1,193 |
| Cilostazol | 22 | $309 |
| Atorvastatin Calcium | 32 | $152 |
| Alprazolam | 89 | $98 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $49 |
| Clonazepam | 26 | $21 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $84 | $21,41229 claims |
| PfizerEliquis | $112 | $17,10219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,596 surgery providers in New York.
Other surgery in Brooklyn
- Nicholas MorinBrooklyn$86K
- Vinod BalachandranNew York$3M
- Stephanie GoffNew York$2.7M
- Alice WeiNew York$2.3M
- Cheguevara AfanehNew York$1.4M
- Thom LoreeBuffalo$1M
- Ajay PanchalAmherst$893K
- Flavio Malcher Martins de OliveiraNew York$814K
- Bonnie LonzeNew York$650K
- Stephen GoldstoneNy$647K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.